Teva looks to amp up research collaborations, CEO says
Teva: Avoid (NYSE:TEVA) | Seeking Alpha
Teva looks to amp up research collaborations, CEO says
DEF 14A
US88163VAE92 Institutional Ownership and Shareholders - Teva Pharmaceutical Fin Llc Bond
Teva Pharma reserves $520 million for FCPA settlement | The FCPA Blog
Teva confirms US FDA warning letter for Hangzhou, China API plant
DEF 14A
TEVA PHARMACEUTICAL INDUSTRIES LTD (FormDEF 14A) - Teva Pharmaceutical Indus (OTC:TEVJF), Teva Pharmaceutical Indus (NYSE:TEVA) - Benzinga
Teva: New Generic Launches Will Benefit Earnings (NYSE:TEVA) | Seeking Alpha
Teva won't say whether R&D cuts include layoffs; Cipla inks deal for Iranian plant; | Fierce Pharma
DEF 14A
TEVA PHARMACEUTICAL INDUSTRIES LTD (FormDEF 14A) - Teva Pharmaceutical Indus (OTC:TEVJF), Teva Pharmaceutical Indus (NYSE:TEVA) - Benzinga
DEF 14A
Form 10-K
DEF 14A
SEC Subpoena For Teva | The FCPA Blog
Capital Research Global Investors increases ownership in TEVJF / Teva Pharmaceutical Industries Ltd.
Teva Investor Relations by Teva Pharmaceuticals USA, Inc.
Teva Pharmaceutical Industries Limited - AnnualReports.com
As U.S. Domestic Issuer, Teva Reveals Top Stock Owners | Ctech
Teva Pharmaceuticals and IBM Expand Global Partnership to Enable Drug Development and Chronic Disease Management with
